Log in to search using one of your social media accounts:

 

HIV vaccine may be just a short step away

Researchers believe they have solved the problem by 'unblocking' a process linked to an HIV protein that was halting the production of antibody-generating 'B-cells' from the immune system.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news

Related Links:

Zenglei Hu, Xinan Jiao, Xiufan Liu
Source: Frontiers in Microbiology - Category: Microbiology Source Type: research
(PATH) Results from a Phase 3 efficacy study in India of the Serum Institute of India Pvt. Ltd.'s rotavirus vaccine BRV-PV (known as ROTASIIL ® ) were published in the journal Vaccine. The study showed the vaccine to be safe, well tolerated, and to provide significant efficacy against severe rotavirus gastroenteritis. In 2013, an estimated 47,100 rotavirus deaths occurred in India, 22 percent of all rotavirus deaths that occurred globally.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
U.S. Department of Health and Human Services. 09/2017 This 42-page document from the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) presents findings on the critical issues that can hinder the development of products to reduce the spread of anti-microbial resistance, and recommendations for incentives on how to address these barriers. To help organize and structure its findings, the report provides a framework, categorizing issues according to four broad buckets: economic, research and development, regulatory, and behavioral. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Authors: Source Type: news
Scientists in the US have developed a new injection which offers promising hope to sufferers of the tick-borne condition.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
Cambridge-based Genocea Biosciences said Monday that it is laying off around 40 of its 100 employees and seeking to unload a genital herpes vaccine program as it shifts its focus to developing cancer treatments. Genocea (Nasdaq: GNCA) said it was ceasing all spending and development activities related to GEN-003, which the company previously touted as a potential blockbuster. Genocea said it was “exploring strategic alternatives” for the vaccine, typically shorthand for a sale or other transaction. T he…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news
Older people who are in a good mood when they get a flu shot have a better immune response.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Vaccination and Immunization Swine Influenza Psychology and Psychologists Immune System Source Type: news
PROVIDENCE, R.I., Sept. 25, 2017 -- (Healthcare Sales &Marketing Network) -- EpiVax, Inc., a leader in the fields of immunogenicity assessment, vaccine design, and immune-engineering today announced the launch of EpiVax Oncology Inc., a company focused o... Biopharmaceuticals, Personalized Medicine, Oncology EpiVax, EpiVax Oncology, epitopes, immunotherapy
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
Almost every patient vaccinated against flu at a community pharmacy last winter would have their vaccination there again, a patient satisfaction  survey carried out by NHS England has found.
Source: The Pharmaceutical Journal - Category: Drugs & Pharmacology Source Type: research
Source: NPR Health and Science - Category: Consumer Health News Authors: Source Type: news
Source: RxList - New and Updated Drug Monographs - Category: Drugs & Pharmacology Source Type: news
More News: Health | Vaccines